Probes for rapid and specific detection of mycobacteria

US10370538B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10370538-B2
Application numberUS-201615001591-A
CountryUS
Kind codeB2
Filing dateJan 20, 2016
Priority dateAug 11, 2015
Publication dateAug 6, 2019
Grant dateAug 6, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The compositions of the present disclosure provide novel fluorogenic probes for use in the specific imaging and detection of mycobacteria species, and in particular β-lactam-antibiotic resistant. Specificity for mycobacteria is conferred on these probes by incorporating a moiety that specifically targets the unique trapping mechanism of the DprE1 found in in mycobacteria. Accordingly, only Mycobacteria species that express both a β-lactamase and DprE1 enable both the activation of the caged fluorescent probe, and the affixing of the released fluorescent probes to the bacteria cells through the functioning reduction-covalent binding mechanism. Advantageously, such a probe is able, at its most sensitive, to allow single mycobacterium detection.

First claim

Opening claim text (preview).

The invention claimed is: 1. A probe specific for a mycobacterium, said probe comprising a β-lactamase substrate group covalently attached to a detectable label group, wherein the β-lactamase substrate group has the formula VI: wherein, in the β-lactamase substrate group: n=0 or 1; R 4 is selected from the group consisting of: a hydrogen, an alkyl, a substituted alkyl, an alkoxy, an alkoxycarbonyl, an alkoxyl, an alkoxyalkyl, an alkylene, an aralkoxycarbonyl, an aralkyl, an aralkyloxyl, an aroyl, an aroylamino, an aryl, a substituted aryl group, a carbamoyl, a carbonyl, a carboxamide, a carboxyl, a heteroaryl, a heterocyclic, a hydroxyalkyl, a substituted alkenyl, a substituted cycloaliphatic, a substituted aliphatic, a thiol, a thioalkoxy, a thioalkyl, a thioaryl, a thiophene, or a substituted thiophene; R 5 is Me, —CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CF 2 CH 3 , —CHF 2 , —CH 2 F, —OCH 2 F, or OCHF 2 ; R 6 and R 7 are each H or  and R 8 is O or S, and wherein the detectable label has a caging group covalently attached thereto by an esterase-cleavable ester bond, wherein the detectable label is a fluorophore or a dye having the caging group covalently attached thereto by an esterase-cleavable ester bond, wherein said caging group is an acetoxymethyl group. 2. A probe specific for a mycobacterium, said probe comprising a β-lactamase substrate group covalently attached to a detectable label group, wherein the β-lactamase substrate group has the formula VI: wherein, in the β-lactamase substrate group: n=0 or 1; R 4 is selected from the group consisting of: a hydrogen, an alkyl, a substituted alkyl, an alkoxy, an alkoxycarbonyl, an alkoxyl, an alkoxyalkyl, an alkylene, an aralkoxycarbonyl, an aralkyl, an aralkyloxyl, an aroyl, an aroylamino, an aryl, a substituted aryl group, a carbamoyl, a carbonyl, a carboxamide, a carboxyl, a heteroaryl, a heterocyclic, a hydroxyalkyl, a substituted alkenyl, a substituted cycloaliphatic, a substituted aliphatic, a thiol, a thioalkoxy, a thioalkyl, a thioaryl, a thiophene, or a substituted thiophene; R 5 is Me, —CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CF 2 CH 3 , —CHF 2 , —CH 2 F, —OCH 2 F, or —OCHF 2 ; R 6 and R 7 are each H or  and R 8 is O or S, and wherein the detectable label has a caging group covalently attached thereto by an esterase-cleavable ester bond, said probe further comprising a mycobacterium -specific decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1)-trapping moiety, or an ester or salt thereof, said DprE1-trapping moiety covalently attached to the detectable label. 3. The probe of claim 2 , wherein said mycobacterium -specific DprE1-trapping moiety is covalently attached to the detectable label by a first linker. 4. The probe of claim 2 , wherein said mycobacterium -specific DprE1-trapping moiety has the formula: and wherein R 1 is H, —NO 2 , or CF 3 . 5. The probe of claim 2 , wherein the first linker is selected from the group consisting of: ethoxyphenyl, —CH 2 —CH 2 —, -1-ethyl 3-methyl 1,2,3-triazole, and —CH 2 —CH 2 —NR 2 —CS—NH 2 —, wherein R 2 is H or —CH 3 . 6. A probe specific for a mycobacterium, wherein the probe is selected from the group consisting of: wherein R 9 is each independently Me, —CH 2 CH 3 , —CF 3 , —CH 2 CF 3 , —CF 2 CH 3 , —CHF 2 , —CH 2 F, —OCH 2 F, or —OCHF 2 .

Assignees

Inventors

Classifications

  • Methylene radicals, substituted by sulfur atoms · CPC title

  • with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms · CPC title

  • C09B11/24Primary

    Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title

  • C12Q1/689Primary

    for bacteria · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10370538B2 cover?
The compositions of the present disclosure provide novel fluorogenic probes for use in the specific imaging and detection of mycobacteria species, and in particular β-lactam-antibiotic resistant. Specificity for mycobacteria is conferred on these probes by incorporating a moiety that specifically targets the unique trapping mechanism of the DprE1 found in in mycobacteria. Accordingly, only Myco…
Who is the assignee on this patent?
Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification C09B11/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).